BI 695501
1297.2
Phase 3 small_molecule completed
Quick answer
BI 695501 for Arthritis, Rheumatoid is a Phase 3 program (small_molecule) at Boehringer Ingelheim with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Boehringer Ingelheim
- Indication
- Arthritis, Rheumatoid
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed